1. Home
  2. ICUI vs BATRA Comparison

ICUI vs BATRA Comparison

Compare ICUI & BATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • BATRA
  • Stock Information
  • Founded
  • ICUI 1984
  • BATRA 1991
  • Country
  • ICUI United States
  • BATRA United States
  • Employees
  • ICUI N/A
  • BATRA N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • BATRA Broadcasting
  • Sector
  • ICUI Health Care
  • BATRA Industrials
  • Exchange
  • ICUI Nasdaq
  • BATRA Nasdaq
  • Market Cap
  • ICUI 3.3B
  • BATRA 2.9B
  • IPO Year
  • ICUI 1992
  • BATRA N/A
  • Fundamental
  • Price
  • ICUI $119.25
  • BATRA $43.85
  • Analyst Decision
  • ICUI Buy
  • BATRA Strong Buy
  • Analyst Count
  • ICUI 6
  • BATRA 3
  • Target Price
  • ICUI $186.60
  • BATRA $58.00
  • AVG Volume (30 Days)
  • ICUI 285.2K
  • BATRA 58.7K
  • Earning Date
  • ICUI 11-11-2025
  • BATRA 11-05-2025
  • Dividend Yield
  • ICUI N/A
  • BATRA N/A
  • EPS Growth
  • ICUI N/A
  • BATRA N/A
  • EPS
  • ICUI N/A
  • BATRA N/A
  • Revenue
  • ICUI $2,372,504,000.00
  • BATRA $702,443,000.00
  • Revenue This Year
  • ICUI N/A
  • BATRA $14.16
  • Revenue Next Year
  • ICUI N/A
  • BATRA $3.97
  • P/E Ratio
  • ICUI N/A
  • BATRA N/A
  • Revenue Growth
  • ICUI 2.96
  • BATRA 6.51
  • 52 Week Low
  • ICUI $107.00
  • BATRA $38.67
  • 52 Week High
  • ICUI $196.26
  • BATRA $50.50
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 42.14
  • BATRA 31.05
  • Support Level
  • ICUI $117.69
  • BATRA $44.55
  • Resistance Level
  • ICUI $125.00
  • BATRA $45.43
  • Average True Range (ATR)
  • ICUI 4.04
  • BATRA 0.66
  • MACD
  • ICUI -0.69
  • BATRA -0.06
  • Stochastic Oscillator
  • ICUI 23.20
  • BATRA 8.80

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

Share on Social Networks: